← Back to Search

Culturally Targeted SARS-CoV-2 Communication for COVID-19

N/A

Waitlist Available

Research Sponsored by Michigan State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 8 weeks

Awards & highlights

Study Summary

This trial will focus on how to best communicate with African Americans in Flint, Michigan about getting a SARS-CoV-2 antibody test through a drive-up saliva sample collection.

Eligible Conditions

COVID-19

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Anticipatory Racism

Salivary Kit Completion

Salivary Kit Request

+1 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: African American Registry: Culturally TargetedExperimental Treatment1 Intervention

African American participants receive culturally targeted video information about SARS-CoV-2 antibody testing.

Group II: White Flint Registry: GeneralActive Control1 Intervention

White participants receive "general consumption" video information about SARS-CoV-2 antibody testing.

Group III: African American Registry: GeneralActive Control1 Intervention

African American participants receive "general consumption" video information about SARS-CoV-2 antibody testing.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Culturally Targeted SARS-CoV-2 Communication

2021

N/A

~530

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,142 Total Patients Enrolled

39 Trials studying COVID-19

1,900,221 Patients Enrolled for COVID-19

Johns Hopkins UniversityOTHER

2,259 Previous Clinical Trials

14,820,128 Total Patients Enrolled

34 Trials studying COVID-19

26,450 Patients Enrolled for COVID-19

Michigan State UniversityLead Sponsor

184 Previous Clinical Trials

600,882 Total Patients Enrolled

2 Trials studying COVID-19

380 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants has the trial accepted thus far?

"Affirmative, the information found on clinicaltrials.gov suggests that this research is currently recruiting participants. This scientific investigation was initially posted on August 4th 2021 and has since been updated as of December 3rd 2021, aiming to recruit 500 subjects from a single medical facility."

Answered by AI

Are there any available vacancies in this medical experiment?

"Affirmative. According to the records on clinicaltrials.gov, this research study is currently recruiting participants which began listing on August 4th 2021 and was updated lastly on December 3rd 2021. For completion of the trial, 500 patients are needed from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake

Todd Lucas 2021. "Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04957082.